SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms

Abstract SHP2 is a ubiquitous tyrosine phosphatase involved in regulating both tumor and immune cell signaling. In this study, we discovered a novel immune modulatory function of SHP2. Targeting this protein with allosteric SHP2 inhibitors promoted anti-tumor immunity, including enhancing T cell cyt...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Ye Wang, Morvarid Mohseni, Angelo Grauel, Javier Estrada Diez, Wei Guan, Simon Liang, Jiyoung Elizabeth Choi, Minying Pu, Dongshu Chen, Tyler Laszewski, Stephanie Schwartz, Jane Gu, Leandra Mansur, Tyler Burks, Lauren Brodeur, Roberto Velazquez, Steve Kovats, Bhavesh Pant, Giri Buruzula, Emily Deng, Julie T. Chen, Farid Sari-Sarraf, Christina Dornelas, Malini Varadarajan, Haiyan Yu, Chen Liu, Joanne Lim, Huai-Xiang Hao, Xiaomo Jiang, Anthony Malamas, Matthew J. LaMarche, Felipe Correa Geyer, Margaret McLaughlin, Carlotta Costa, Joel Wagner, David Ruddy, Pushpa Jayaraman, Nathaniel D. Kirkpatrick, Pu Zhang, Oleg Iartchouk, Kimberly Aardalen, Viviana Cremasco, Glenn Dranoff, Jeffrey A. Engelman, Serena Silver, Hongyun Wang, William D. Hastings, Silvia Goldoni
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/aeca1d5b6b344aeabcc21b726ae4f617
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:aeca1d5b6b344aeabcc21b726ae4f617
record_format dspace
spelling oai:doaj.org-article:aeca1d5b6b344aeabcc21b726ae4f6172021-12-02T14:01:22ZSHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms10.1038/s41598-021-80999-x2045-2322https://doaj.org/article/aeca1d5b6b344aeabcc21b726ae4f6172021-01-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-80999-xhttps://doaj.org/toc/2045-2322Abstract SHP2 is a ubiquitous tyrosine phosphatase involved in regulating both tumor and immune cell signaling. In this study, we discovered a novel immune modulatory function of SHP2. Targeting this protein with allosteric SHP2 inhibitors promoted anti-tumor immunity, including enhancing T cell cytotoxic function and immune-mediated tumor regression. Knockout of SHP2 using CRISPR/Cas9 gene editing showed that targeting SHP2 in cancer cells contributes to this immune response. Inhibition of SHP2 activity augmented tumor intrinsic IFNγ signaling resulting in enhanced chemoattractant cytokine release and cytotoxic T cell recruitment, as well as increased expression of MHC Class I and PD-L1 on the cancer cell surface. Furthermore, SHP2 inhibition diminished the differentiation and inhibitory function of immune suppressive myeloid cells in the tumor microenvironment. SHP2 inhibition enhanced responses to anti-PD-1 blockade in syngeneic mouse models. Overall, our study reveals novel functions of SHP2 in tumor immunity and proposes that targeting SHP2 is a promising strategy for cancer immunotherapy.Ye WangMorvarid MohseniAngelo GrauelJavier Estrada DiezWei GuanSimon LiangJiyoung Elizabeth ChoiMinying PuDongshu ChenTyler LaszewskiStephanie SchwartzJane GuLeandra MansurTyler BurksLauren BrodeurRoberto VelazquezSteve KovatsBhavesh PantGiri BuruzulaEmily DengJulie T. ChenFarid Sari-SarrafChristina DornelasMalini VaradarajanHaiyan YuChen LiuJoanne LimHuai-Xiang HaoXiaomo JiangAnthony MalamasMatthew J. LaMarcheFelipe Correa GeyerMargaret McLaughlinCarlotta CostaJoel WagnerDavid RuddyPushpa JayaramanNathaniel D. KirkpatrickPu ZhangOleg IartchoukKimberly AardalenViviana CremascoGlenn DranoffJeffrey A. EngelmanSerena SilverHongyun WangWilliam D. HastingsSilvia GoldoniNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-23 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Ye Wang
Morvarid Mohseni
Angelo Grauel
Javier Estrada Diez
Wei Guan
Simon Liang
Jiyoung Elizabeth Choi
Minying Pu
Dongshu Chen
Tyler Laszewski
Stephanie Schwartz
Jane Gu
Leandra Mansur
Tyler Burks
Lauren Brodeur
Roberto Velazquez
Steve Kovats
Bhavesh Pant
Giri Buruzula
Emily Deng
Julie T. Chen
Farid Sari-Sarraf
Christina Dornelas
Malini Varadarajan
Haiyan Yu
Chen Liu
Joanne Lim
Huai-Xiang Hao
Xiaomo Jiang
Anthony Malamas
Matthew J. LaMarche
Felipe Correa Geyer
Margaret McLaughlin
Carlotta Costa
Joel Wagner
David Ruddy
Pushpa Jayaraman
Nathaniel D. Kirkpatrick
Pu Zhang
Oleg Iartchouk
Kimberly Aardalen
Viviana Cremasco
Glenn Dranoff
Jeffrey A. Engelman
Serena Silver
Hongyun Wang
William D. Hastings
Silvia Goldoni
SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms
description Abstract SHP2 is a ubiquitous tyrosine phosphatase involved in regulating both tumor and immune cell signaling. In this study, we discovered a novel immune modulatory function of SHP2. Targeting this protein with allosteric SHP2 inhibitors promoted anti-tumor immunity, including enhancing T cell cytotoxic function and immune-mediated tumor regression. Knockout of SHP2 using CRISPR/Cas9 gene editing showed that targeting SHP2 in cancer cells contributes to this immune response. Inhibition of SHP2 activity augmented tumor intrinsic IFNγ signaling resulting in enhanced chemoattractant cytokine release and cytotoxic T cell recruitment, as well as increased expression of MHC Class I and PD-L1 on the cancer cell surface. Furthermore, SHP2 inhibition diminished the differentiation and inhibitory function of immune suppressive myeloid cells in the tumor microenvironment. SHP2 inhibition enhanced responses to anti-PD-1 blockade in syngeneic mouse models. Overall, our study reveals novel functions of SHP2 in tumor immunity and proposes that targeting SHP2 is a promising strategy for cancer immunotherapy.
format article
author Ye Wang
Morvarid Mohseni
Angelo Grauel
Javier Estrada Diez
Wei Guan
Simon Liang
Jiyoung Elizabeth Choi
Minying Pu
Dongshu Chen
Tyler Laszewski
Stephanie Schwartz
Jane Gu
Leandra Mansur
Tyler Burks
Lauren Brodeur
Roberto Velazquez
Steve Kovats
Bhavesh Pant
Giri Buruzula
Emily Deng
Julie T. Chen
Farid Sari-Sarraf
Christina Dornelas
Malini Varadarajan
Haiyan Yu
Chen Liu
Joanne Lim
Huai-Xiang Hao
Xiaomo Jiang
Anthony Malamas
Matthew J. LaMarche
Felipe Correa Geyer
Margaret McLaughlin
Carlotta Costa
Joel Wagner
David Ruddy
Pushpa Jayaraman
Nathaniel D. Kirkpatrick
Pu Zhang
Oleg Iartchouk
Kimberly Aardalen
Viviana Cremasco
Glenn Dranoff
Jeffrey A. Engelman
Serena Silver
Hongyun Wang
William D. Hastings
Silvia Goldoni
author_facet Ye Wang
Morvarid Mohseni
Angelo Grauel
Javier Estrada Diez
Wei Guan
Simon Liang
Jiyoung Elizabeth Choi
Minying Pu
Dongshu Chen
Tyler Laszewski
Stephanie Schwartz
Jane Gu
Leandra Mansur
Tyler Burks
Lauren Brodeur
Roberto Velazquez
Steve Kovats
Bhavesh Pant
Giri Buruzula
Emily Deng
Julie T. Chen
Farid Sari-Sarraf
Christina Dornelas
Malini Varadarajan
Haiyan Yu
Chen Liu
Joanne Lim
Huai-Xiang Hao
Xiaomo Jiang
Anthony Malamas
Matthew J. LaMarche
Felipe Correa Geyer
Margaret McLaughlin
Carlotta Costa
Joel Wagner
David Ruddy
Pushpa Jayaraman
Nathaniel D. Kirkpatrick
Pu Zhang
Oleg Iartchouk
Kimberly Aardalen
Viviana Cremasco
Glenn Dranoff
Jeffrey A. Engelman
Serena Silver
Hongyun Wang
William D. Hastings
Silvia Goldoni
author_sort Ye Wang
title SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms
title_short SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms
title_full SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms
title_fullStr SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms
title_full_unstemmed SHP2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms
title_sort shp2 blockade enhances anti-tumor immunity via tumor cell intrinsic and extrinsic mechanisms
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/aeca1d5b6b344aeabcc21b726ae4f617
work_keys_str_mv AT yewang shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT morvaridmohseni shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT angelograuel shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT javierestradadiez shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT weiguan shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT simonliang shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT jiyoungelizabethchoi shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT minyingpu shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT dongshuchen shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT tylerlaszewski shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT stephanieschwartz shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT janegu shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT leandramansur shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT tylerburks shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT laurenbrodeur shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT robertovelazquez shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT stevekovats shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT bhaveshpant shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT giriburuzula shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT emilydeng shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT julietchen shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT faridsarisarraf shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT christinadornelas shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT malinivaradarajan shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT haiyanyu shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT chenliu shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT joannelim shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT huaixianghao shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT xiaomojiang shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT anthonymalamas shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT matthewjlamarche shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT felipecorreageyer shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT margaretmclaughlin shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT carlottacosta shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT joelwagner shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT davidruddy shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT pushpajayaraman shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT nathanieldkirkpatrick shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT puzhang shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT olegiartchouk shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT kimberlyaardalen shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT vivianacremasco shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT glenndranoff shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT jeffreyaengelman shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT serenasilver shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT hongyunwang shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT williamdhastings shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
AT silviagoldoni shp2blockadeenhancesantitumorimmunityviatumorcellintrinsicandextrinsicmechanisms
_version_ 1718392161839349760